(7S-cis)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione hydrochloride (57852-57-0)

Identification
Synonyms:	Idarubicin Hydrochloride
CAS:	57852-57-0
EINECS:	260-990-7
Molecular Formula:	C26H27NO9?HCl
Molecular Weight:	533.95
InChI:	InChI=1/C26H27NO9.ClH/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31;/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3;1H/t10?,15?,16-,17?,21?,26-;/m0./s1
Molecular Structure:
Properties
Transport:	UN 2811
Storage Temperature:	2-8°C
Usage:	4-Demethoxydaunorubicin hydro-chloride (CAS NO.57852-57-0) is orally active anthracycline , analog of Daunorubicin and Antineoplastic.
Safety Data
Hazard Symbols	T+:Verytoxic

Other Product

5,12-Naphthacenedione,9-acetyl-6-amino-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-9,11-dihydroxy-,(7S-cis)- (9CI)
5,12-Naphthacenedione,9-acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9-dihydroxy-,(7S-cis)- (9CI)
5,12-Naphthacenedione,9-acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-2-fluoro-7,8,9,10-tetrahydro-6,9,11-trihydroxy-,(7S-cis)- (9CI)
5,12-Naphthacenedione,7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-methyl-1-oxopropyl)-,hydrochloride, (7S-cis)- (9CI)
5,12-Naphthacenedione,7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-9-ethyl-7,8,9,10-tetrahydro-1,4,6,9,11-pentahydroxy-,(7S-cis)- (9CI)
5,12-Naphthacenedione,7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9-dihydroxy-9-(hydroxyacetyl)-,(7S-cis)- (9CI)
5,12-Naphthacenedione,9-acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-9-methyl-,hydrochloride, (7S-trans)- (9CI)
5,12-Naphthacenedione,9-acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-,(7S,9S)-
5,12-Naphthacenedione,9-acetyl-7-[(3-amino-2,3,6-trideoxy-b-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-,(7S-cis)- (9CI)
5,12-Naphthacenedione,7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-hydroxy-1-methylethyl)-,hydrochloride, (7S-cis)- (9CI)
5,12-Naphthacenedione,7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-oxopentyl)-,hydrochloride, (7S-cis)- (9CI)
5,12-Naphthacenedione,7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-oxononyl)-,hydrochloride, (7S-cis)- (9CI)
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-9-(1-hydroxyethyl)-, hydrochloride, (7S-(7-alpha,9-alpha,9(S*)))-
5,12-Naphthacenedione,7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-,(7S,9S)-
5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-beta-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7R-cis)-
5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9-dihydroxy-, (7S-cis)-
5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9, 10-tetrahydro-6,8,11-trihydroxy-1,9-dimethoxy-, hydrochloride, [8S-(8.alpha.,9.beta.,10.alpha.)]-
5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8, 11-trihydroxy-1-methoxy-10-[[2,3, 6-trideoxy-3-(4-morpholinyl)-.alpha.-L-lyxo-hexopyranosyl]oxy]-, hydrochloride, (8S-cis)-
5,12-Naphthacenedione, 7-((4-O-(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)-2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-, (7S,9S)-
5,12-Naphthacenedione,7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-,hydrochloride, (7S,9S)- (9CI)